Shareholders' Equity

9 Months Ended

Jun. 28, 2025

Stockholders' Equity Note [Abstract]

Shareholders' Equity

Shareholders' Equity

On August 18, 2022, the Board of Directors approved a share repurchase program under which the Company was authorized to repurchase up to $50.0 million of its common stock (the "2023 Program"). The 2023 program completed in February 2024. During the nine months ended June 29, 2024, the Company repurchased 59,277 shares under this program for $5.7 million at an average price of $95.59 per share.

On January 16, 2024, the Company announced a share repurchase program authorized by the Board of Directors under which the Company was authorized to repurchase up to $50.0 million of its common stock (the "2024 Program"). The 2024 Program commenced upon completion of the 2023 Program and was completed in fiscal 2024. During the three months ended June 29, 2024, the Company repurchased 184,581 shares under this program for $18.6 million at an average price of $100.64 per share. During the nine months ended June 29, 2024, the Company repurchased 311,431 shares under this program for $30.5 million at an average price of $97.87 per share.

On August 14, 2024, the Board of Directors approved a share repurchase program under which the Company is authorized to repurchase up to $50.0 million of its common stock (the "2025 Program"). The 2025 Program became effective upon completion of the 2024 Program and has no expiration. During the three months ended June 28, 2025, the Company purchased 143,282 shares under this program for $18.4 million at an average price of $128.70 per share. During the nine months ended June 28, 2025, the Company repurchased 314,344 shares under this program for $43.4 million at an average price of $138.19 per share. The nine months ended June 28, 2025 purchased amounts exclude excise tax on share repurchases of $0.4 million. As of June 28, 2025, $6.6 million of authority remained under the 2025 Program, which has since been fully expended.

On May 14, 2025, the Board of Directors approved a share repurchase program under which the Company is authorized to repurchase up to $100.0 million of its common stock (the “2026 Program”). The 2026 Program became effective upon completion of the 2025 Program and has no expiration.

All shares repurchased under the aforementioned programs were recorded as treasury stock.